Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial save search
Industrial Starch Market Size Worth $167.50 Billion By 2028 | CAGR: 7.0%: Grand View Research, Inc.
Published: 2021-08-31 (Crawled : 09:00) - prnewswire.com
INGR G | $114.33 0.02% 0.0% 180K
|
Process Industries
|
| O: 0.16%
H: 0.9%
C: -0.06%
research trial
Relief Reports that U.S. Collaboration Partner has Announced a New Finding from Aviptadil Phase 2b/3 Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19
Published: 2021-08-31 (Crawled : 07:00) - biospace.com/
NRXP 5 d | $3.05 1.67% 3.23% 100K
|
Manufacturing
|
| O: -1.11%
H: 8.62%
C: 8.07%
covid phase 2 collaboration respiratory phase 2b trial aviptadil
Lear to Participate in RBC Capital Markets Global Industrials Conference
Published: 2021-08-30 (Crawled : 21:00) - prnewswire.com
LEA | $133.53 -0.44% 0.0% 690K
|
Producer Manufacturing
|
| O: -0.17%
H: 0.71%
C: -0.4%
trial conference
Novavax Statement on CDC Guidance Update for COVID-19 Clinical Trial Participants
Published: 2021-08-30 (Crawled : 21:00) - biospace.com/
NVAX | $4.19 2.95% 3.21% 3M
|
Health Technology
|
| O: -1.04%
H: 6.19%
C: 3.98%
covid trial covid-19
OPKO Health Completes Enrollment in Phase 2 Trial Evaluating RAYALDEE as a Treatment for Symptomatic COVID-19 Outpatients
Published: 2021-08-30 (Crawled : 21:00) - globenewswire.com
OPK | $1.25 1.63% 1.2% 1.7M
|
Health Technology
|
| O: -0.26%
H: 1.31%
C: 0.78%
covid treatment phase 2 trial enroll
Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke
Published: 2021-08-30 (Crawled : 16:00) - prnewswire.com
ABT | News | $107.59 0.49% 0.33% 3.1M
|
Health Technology
|
| O: -0.05%
H: 1.33%
C: 1.13%
stroke risk device trial
Biomerica expects Completion of Patient Enrollment for its InFoods® Diagnostic-Guided Therapy Irritable Bowel Syndrome Clinical Trial this week
Published: 2021-08-30 (Crawled : 14:00) - biospace.com/
BMRA | $0.722 -0.37% 0.73% 48K
|
Health Technology
|
| O: -3.29%
H: 8.76%
C: 6.08%
food therapy trial syndros enroll diagnostic
Anixa Biosciences and Moffitt Cancer Center Announce FDA Clearance to Initiate Clinical Trial of Ovarian Cancer CAR-T Immunotherapy
Published: 2021-08-30 (Crawled : 13:00) - biospace.com/
ANIX | $3.07 1.99% 1.63% 72K
|
Health Technology
|
| O: 5.89%
H: 9.56%
C: 2.28%
fda clearance fda immunotherapy therapy car-t cancer ovarian cancer trial clearance
NRx Pharmaceuticals Announces New Finding from ZYESAMI™ (aviptadil) Phase 2b/3 Clinical Trial Demonstrating Clinically Significant Relief from Respiratory Distress in Critical COVID-19
Published: 2021-08-30 (Crawled : 12:15) - prnewswire.com
NRXP 5 d | $3.05 1.67% 3.23% 100K
|
Manufacturing
|
| O: 11.53%
H: 11.56%
C: -0.07%
covid phase 2 respiratory phase 2b trial aviptadil
uniQure Announces Completion of Additional Patient Procedures Following Positive Recommendation from Data Safety Monitoring Board in Phase I/II Clinical Trial of AMT-130 for the Treatment of Huntington’s Disease
Published: 2021-08-30 (Crawled : 12:00) - biospace.com/
QURE | $4.75 -1.45% -1.37% 460K
|
Health Technology
|
| O: 3.72%
H: 1.12%
C: -2.74%
huntington disease treatment positive trial huntington’s disease
Positive Top-Line Results From Pfizer’s Phase 3 JADE DARE Trial Comparing the Efficacy of Abrocitinib and Dupilumab for Moderate to Severe Atopic Dermatitis
Published: 2021-08-30 (Crawled : 11:00) - biospace.com/
PFE | News 4 | $26.32 0.23% 0.15% 20M
|
Health Technology
|
| O: -2.47%
H: 2.08%
C: 1.21%
positive results dermatitis phase 3 trial topline atopic dermatitis
CNH Industrial signs agreement to acquire excavator manufacturer Sampierana S.p.A
Published: 2021-08-30 (Crawled : 06:00) - globenewswire.com
CNHI | $11.58 0.7% -0.09% 15M
|
Producer Manufacturing
|
| O: 1.23%
H: 0.3%
C: -0.36%
trial
VirTra Scales Manufacturing Capabilities with Purchase of Industrial Building in Chandler, Arizona
Published: 2021-08-30 (Crawled : 05:00) - virtra.com
VTSI | $12.31 0.74% 0.73% 150K
|
Producer Manufacturing
|
| O: 3.16%
H: 6.67%
C: 5.6%
trial
Dupixent® (dupilumab) pivotal trial meets all primary and secondary endpoints becoming first biologic medicine to significantly reduce signs and symptoms of moderate-to-severe atopic dermatitis in children as young as 6 months
Published: 2021-08-30 (Crawled : 05:00) - globenewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: 0.25%
H: 0.46%
C: -0.46%
REGN | News | $907.32 0.8% 0.74% 220K
|
Health Technology
|
| O: -0.63%
H: 2.21%
C: 1.97%
dermatitis children trial atopic dermatitis dupixent
Entertainment Robots Market from Industrial Machinery Sector to Accelerate at 12.21% CAGR during 2021-2025 | Hasbro Inc. and Mattel Inc. Emerge as Dominant Vendors | Technavio
Published: 2021-08-27 (Crawled : 23:00) - prnewswire.com
SNEJF | News | $81.888 0.5% 2.78% 42K
|
Consumer Durables
| Email alert
Add to watchlist
trial merge
Photo Release — Ingalls Shipbuilding Successfully Completes Builder’s Trials for Frank E. Petersen Jr. (DDG 121)
Published: 2021-08-27 (Crawled : 19:00) - globenewswire.com
HII | $274.47 -0.01% 0.0% 240K
|
Electronic Technology
| Email alert
Add to watchlist
trial
Europe Biosimilars Market, Dosage, Price, Sales & Clinical Trials Report 2021-2026: Adalimumab (Humira) is Currently Dominating the $10 Billion Market
Published: 2021-08-27 (Crawled : 18:00) - prnewswire.com
SNY | News | $47.69 1.15% 1.13% 1.6M
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
sales europe clinical trials trial biosimilar
Landmark trial demonstrates Jardiance® (empagliflozin) is the first therapy to show statistically significant improvement in heart failure outcomes in adults with preserved ejection fraction
Published: 2021-08-27 (Crawled : 16:00) - prnewswire.com
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
heart therapy trial
Facilities Management Market to Record 8.30% CAGR by 2025 | Aramark Corp. and Interserve Group Ltd. Emerge as Dominant Players in Industrial Machinery Industry | Technavio
Published: 2021-08-27 (Crawled : 15:00) - prnewswire.com
JCI | News S | $65.17 0.82% 0.03% 2.7M
|
Producer Manufacturing
|
| O: 0.55%
H: 0.61%
C: -0.6%
ARMK | $32.1 -0.47% 0.0% 1.8M
|
Consumer Services
|
| O: 0.61%
H: 0.0%
C: 0.0%
trial merge
Tenneco To Webcast Remarks At The 2021 RBC Capital Markets Global Industrials Conference
Published: 2021-08-27 (Crawled : 15:00) - prnewswire.com
TEN | $19.99 0.0%
|
Producer Manufacturing
|
| O: 0.58%
H: 8.09%
C: 5.16%
trial conference
Gainers vs Losers
| 77% | 23% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
RVYL A 6 d | $1.6463 25.19% 20.54% 860K
|
Manufacturing
VLCN | $0.2946 26.38% 20.17% 15M
|
MLEC | $1.73 23.57% 19.54% 3.1M
|
n/a
WISA 4 | $5.39 24.77% 19.4% 8.7M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.